Protex Healthcare was incorporated in the United Kingdom in 1999 with the aim of developing Vacutex™, our unique rapid capillary action wound dressing.
Vacutex™ has been carefully developed as part of a wider portfolio of wound management products over the past ten years, and is now an internationally recognised solution for advanced wound care in difficult to heal wounds such as venous leg ulcers, diabetic foot ulcers, pressure sores and other chronic wounds or ulcers.
Following a three-year development period, which included a large multi-centred random clinical trial and an independent audit, Vacutex™ was immediately accepted into the UK NHS reimbursement regime under a newly created separate reimbursement category. This reflects its innovative and unique stature as a leading global wound management solution.
Protex Healthcare products, including Vacutex™ and its new range extensions, are now available across the world with dedicated distributors in the UK, Belgium, Luxemburg, Germany, Austria, Switzerland, Australia, New Zealand, Rumania, Greece, Portugal and the United States. Other countries are in preparation or in start-up.
Protex Healthcare also launches at Medica 2016 a new range of Wound Care Essentials, in order to support nurses with those products they need in their everyday practice, at excellent price/quality relation.
Protex is looking for more dedicated and strategic distribution partners in many more countries all over the world, with a focus on service and sales towards wound care specialists.
If you are interested in becoming one of our strategic distribution partners in your country, please email us at email@example.com